Kyowa Kirin Co., Ltd. (TSE: 4151) today announced that results of the Phase 3 ROCKET IGNITE trial of rocatinlimab, an investigational therapy targeting the OX40 receptor (OX40R) in patients with ...

Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a late-stage immunotherapy company targeting cancer ...

Results show dosing intervals increasing by two weeks or longer for patients with diabetic macular edema and neovascular (wet) age-related macular degeneration who switch to Eylea HD.

Antengene Corporation Limited ('Antengene', SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical ...

Investing.com -- Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP) stock rose 2.4% following the announcement that an abstract on its CRB-701 clinical study has been accepted for presentation at the ...

Holdings announced that an abstract on updated clinical data from its Phase 1/2 clinical study conducted in the ...

Conference call begins at 4:30 p.m. Eastern time todayMIAMI, July 31, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and six ...

In designer Michael Villbracht’s 1981 fashion show, Iman matched her multicolor poncho with an eccentric makeup look straight ...

For Suga, artmaking is an exercise in both phenomenology and epistemology, questioning the very “thingness” of a thing.

Q2 2025 Earnings Call Transcript July 30, 2025 GE HealthCare Technologies Inc. beats earnings expectations. Reported EPS is ...